Teva Recalls One Lot of Anagrelide Capsules, USP 0.5 mg


Pharmaceutical Recall Related Images

pharmedica usa purely soothing 15% msm drops
biOrigins-branded sodium hydroxide – 500 grams bag
atovaquone oral suspension
Anagrelide Capsules
Anagrelide Capsules

Parsippany, NJ. Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary recall was initiated due to dissolution test failure detected during routine stability testing. No other lots are impacted.

Administration of this product with lower dissolution – taking longer to dissolve once ingested -- may result in decreased effectiveness or ineffectiveness of the drug to exert its platelet-reducing effect. Failed dissolution can result in a slower rate and extent of drug release leading to less anagrelide available in the body. For seriously ill patients with elevated platelet counts, less available anagrelide in the body could increase the risk of clotting (blood coagulation) and clotting or bleeding events such as a heart attack or stroke, which could be life threatening. To date, Teva has not received any product quality complaints or adverse event reports, of this nature, for the recalled lot.

Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. Information about the affected lot is listed in the table below. It is packed in bottles with 100 Capsules. Teva distributed 4224 bottles nationwide from 07-30-2020 through 09-02-2020 to its wholesale, distributor and retail customers under the label for Teva Pharmaceuticals USA, Inc.

NDCLot #Exp. Date
0172-5241-60GD0109005/2022

Teva notified its customers on May 11, 2022, alerting them that the lot was recalled and requesting that they return impacted product. Instructions for returning recalled product and receiving a credit are given in the customer recall letter (Anagrelide Recall 05 2022 Direct Accounts Letter Consumer Level 20 MAY 2022.pdf) and consumer recall letter (Anagrelide Recall 05 2022 _Patient Letter 20 MAY 2022.pdf) released by Teva.

Consumers with questions or concerns should first consult with their health care provider(s). To report an Adverse Event or Quality Complaint, or if you have Medical Related Questions, please use the following contact information:

Medical-related Questions or to report an Adverse Event:
Contact Medical Information at: 888-838-2872, option 3, then, option 4
Live calls received: M - F, 9:00 AM - 5:00 PM Eastern Time; Voicemail: 24 hrs./day, 7 days/week
24 hrs. /day, 7 days/week or by email at druginfo@tevapharm.com.
Product Quality Complaint-related Questions:
Contact Quality Assurance Services:  888-838-2872, option 4
Live calls received: M - F, 9:00 AM - 5:00 PM Eastern Time; Voicemail: 24 hrs./day, 7 days/week

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Original recall and updates at FDA


Related Posts

medical recall
Suntegrity Skincare Recalls Suntegrity Impeccable Skin Sunscreen Foundation
Suntegrity Skincare Recalls Suntegrity Impeccable Skin Sunscreen Foundation
penn herb company nature’s wonderland thyroid formula
Penn Herb Company Ltd Recalls Nature’s Wonderland Thyroid Formula
Penn Herb Company Ltd Recalls Nature’s Wonderland Thyroid Formula
medical recall
Integrity Products Recalls Ram It & To The Moon Capsules
Integrity Products Recalls Ram It & To The Moon Capsules
medline bed assist bar
Medline Industries Recalls 1.5 Million Adult Portable Bed Rails – Two Deaths Reported
Medline Industries Recalls 1.5 Million Adult Portable Bed Rails - Two Deaths Reported

Latest Posts

aahu barah logo
AAHU BARAH USA INC. Recalls 19 Boxes of Aahu Barah Apricot Roll
villa nueva interservices arepa de choclo
Villa Nueva Interservices LLC. Recalls “Arepas LA Mejor” 25 oz bags of Arepa de Choclo
medical recall
Suntegrity Skincare Recalls Suntegrity Impeccable Skin Sunscreen Foundation
penn herb company nature’s wonderland thyroid formula
Penn Herb Company Ltd Recalls Nature’s Wonderland Thyroid Formula
bambu lab a1 printer
Bambu Lab Recalls A1 3D Printers Due to Electric Shock and Fire Hazards

Leave a Reply

Your email address will not be published. Required fields are marked *

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.